Midcap Value Alert: 3 Years of Subscription at the Price of 1
Here is the latest financial fact sheet of PANACEA BIOTECH. For more details, see the PANACEA BIOTECH quarterly results and PANACEA BIOTECH share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.0 |
No. of shares | m | 61.25 |
1 Week | % | -3.6 |
1 Month | % | -6.5 |
1 Year | % | 11.2 |
52 week H/L | Rs | 202.2/113.6 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
PANACEA BIOTECH EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 354 | 215 | 265 | 454 | 191 | |
Low | Rs | 138 | 90 | 110 | 148 | 107 | |
Sales per share (Unadj.) | Rs | 74.6 | 88.8 | 102.0 | 108.0 | 75.1 | |
Earnings per share (Unadj.) | Rs | 6.1 | -31.8 | -23.9 | 176.1 | -5.5 | |
Diluted earnings per share | Rs | 6.1 | -31.8 | -23.9 | 176.1 | -5.5 | |
Cash flow per share (Unadj.) | Rs | 15.1 | -24.6 | -16.4 | 183.2 | 0.9 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 57.2 | 27.2 | -37.3 | 143.1 | 137.7 | |
Adj. book value per share | Rs | 57.2 | 27.2 | -37.3 | 143.1 | 137.7 | |
Shares outstanding (eoy) | m | 61.25 | 61.25 | 61.25 | 61.25 | 61.25 | |
Price / Sales ratio | x | 3.3 | 1.7 | 1.8 | 2.8 | 2.0 | |
Avg P/E ratio | x | 40.1 | -4.8 | -7.9 | 1.7 | -27.1 | |
P/CF ratio (eoy) | x | 16.3 | -6.2 | -11.4 | 1.6 | 170.0 | |
Price / Book Value ratio | x | 4.3 | 5.6 | -5.0 | 2.1 | 1.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 15,062 | 9,325 | 11,498 | 18,427 | 9,142 | |
Total wages/salary | Rs m | 1,471 | 1,444 | 1,562 | 1,830 | 1,265 |
PANACEA BIOTECH INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,567 | 5,441 | 6,248 | 6,612 | 4,599 | |
Other income | Rs m | 51 | 304 | 100 | 110 | 517 | |
Total revenues | Rs m | 4,618 | 5,744 | 6,348 | 6,722 | 5,116 | |
Gross profit | Rs m | 2,009 | 101 | 767 | 16,630 | 47 | |
Depreciation | Rs m | 550 | 441 | 456 | 438 | 391 | |
Interest | Rs m | 1,048 | 1,740 | 1,853 | 1,808 | 44 | |
Profit before tax | Rs m | 461 | -1,777 | -1,442 | 14,494 | 128 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 86 | 170 | 20 | 3,710 | 466 | |
Profit after tax | Rs m | 375 | -1,946 | -1,462 | 10,783 | -337 | |
Gross profit margin | % | 44.0 | 1.9 | 12.3 | 251.5 | 1.0 | |
Effective tax rate | % | 18.6 | -9.5 | -1.4 | 25.6 | 363.5 | |
Net profit margin | % | 8.2 | -35.8 | -23.4 | 163.1 | -7.3 |
PANACEA BIOTECH BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 5,079 | 6,833 | 4,742 | 9,506 | 5,623 | |
Current liabilities | Rs m | 9,383 | 6,221 | 4,472 | 7,738 | 3,297 | |
Net working cap to sales | % | -94.2 | 11.2 | 4.3 | 26.7 | 50.6 | |
Current ratio | x | 0.5 | 1.1 | 1.1 | 1.2 | 1.7 | |
Inventory Days | Days | 16 | 130 | 14 | 61 | 59 | |
Debtors Days | Days | 71 | 46 | 49 | 45 | 48 | |
Net fixed assets | Rs m | 8,478 | 8,753 | 6,664 | 7,446 | 7,028 | |
Share capital | Rs m | 61 | 61 | 61 | 61 | 61 | |
"Free" reserves | Rs m | 3,443 | 1,607 | -2,348 | 8,705 | 8,375 | |
Net worth | Rs m | 3,504 | 1,668 | -2,287 | 8,766 | 8,436 | |
Long term debt | Rs m | 461 | 6,131 | 7,351 | 341 | 202 | |
Total assets | Rs m | 13,557 | 15,585 | 11,774 | 17,351 | 12,712 | |
Interest coverage | x | 1.4 | 0 | 0.2 | 9.0 | 3.9 | |
Debt to equity ratio | x | 0.1 | 3.7 | -3.2 | 0 | 0 | |
Sales to assets ratio | x | 0.3 | 0.3 | 0.5 | 0.4 | 0.4 | |
Return on assets | % | 10.5 | -1.3 | 3.3 | 72.6 | -2.3 | |
Return on equity | % | 10.7 | -116.7 | 63.9 | 123.0 | -4.0 | |
Return on capital | % | 38.1 | -0.5 | 8.1 | 179.0 | 2.0 | |
Exports to sales | % | 20.9 | 26.8 | 34.8 | 18.2 | 43.3 | |
Imports to sales | % | 6.0 | 14.8 | 9.0 | 22.4 | 24.4 | |
Exports (fob) | Rs m | 954 | 1,460 | 2,176 | 1,205 | 1,992 | |
Imports (cif) | Rs m | 273 | 807 | 560 | 1,484 | 1,124 | |
Fx inflow | Rs m | 1,203 | 1,573 | 2,270 | 1,236 | 1,992 | |
Fx outflow | Rs m | 741 | 878 | 657 | 1,735 | 1,191 | |
Net fx | Rs m | 462 | 695 | 1,613 | -499 | 801 |
PANACEA BIOTECH CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,048 | -305 | 1,068 | -1,084 | -4,225 | |
From Investments | Rs m | -53 | -348 | -477 | 12,826 | 4,303 | |
From Financial Activity | Rs m | -1,011 | 907 | -471 | -11,758 | -184 | |
Net Cashflow | Rs m | -20 | 258 | 119 | -17 | -105 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Rajesh Jain | COMP SEC: Vinod Goel | YEAR OF INC: 1984 | BSE CODE: 531349 | FV (Rs): 1 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare PANACEA BIOTECH With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.